Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.

Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.

Item
http://www.wikidata.org/entity/Q34363207
Interventions for reducing diarrhoea in patients receiving chemotherapy for colorectal cancerPulmonary metabolism of resveratrol: in vitro and in vivo evidenceChemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management.Chemotherapy induced diarrhea.A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumorsThe number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018)Dose escalation of intravenous irinotecan using oral cefpodoxime: a phase I study in pediatric patients with refractory solid tumorsEfficacy of long-acting release octreotide for preventing chemotherapy-induced diarrhoea: protocol for a systematic reviewA randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea.Preventive Effects of a Chinese Herbal Formula, Shengjiang Xiexin Decoction, on Irinotecan-Induced Delayed-Onset Diarrhea in Rats.Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.A phase II, randomized, double blind trial of calcium aluminosilicate clay versus placebo for the prevention of diarrhea in patients with metastatic colorectal cancer treated with irinotecan.Rapid deconjugation of SN-38 glucuronide and adsorption of released free SN-38 by intestinal microorganisms in rat.Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression.CPT-11-Induced Delayed Diarrhea Develops via Reduced Aquaporin-3 Expression in the Colon.Is there a role for charcoal in palliative diarrhea management?Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.
P2860

Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.

Item
http://www.wikidata.org/entity/Q34363207
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
@ast
Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
@en
Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
@nl
type
label
Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
@ast
Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
@en
Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
@nl
prefLabel
Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
@ast
Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
@en
Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Phase II study of activated charcoal to prevent irinotecan-induced diarrhea.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921